Patients with aggressive B‐cell lymphoma receiving CAR T‐cell therapy have a low rate of severe infections despite lack of universal antibacterial and antifungal prophylaxis
Pernas, B., Iacoboni, G., Los‐Arcos, I., Carpio, C., Márquez‐Algaba, E., Sanchez‐Salinas, M. A., Albasanz, A., Esperalba, J., Viñado, B., Camps, I. Ruiz, Barba, P.
Published in European journal of haematology (01.08.2024)
Published in European journal of haematology (01.08.2024)
Get full text
Journal Article